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The effects ofprobiotic bacteria Enterococcus faecium (EF) and selenium were studied on methotrexate
(MTX) treatment in rats with adjuvant arthritis (AA).
Arthritic rats were preventive treated orally with the following substances: lyophilized EF
(15mg/kg/day, 5 days a week); sodium selenite pentahydrate (SSe, 0.050mg/kg containing
0.015mg/kg selenium, 5 days a week); MTX (0.6mg/kg/week), and their combinations for the period
of 50 days from adjuvant application. Levels of serum albumin, serum nitrite/nitrate concentrations,
hind paw swelling, arthrogram scores, whole body bone mineral density (BMD), and bone erosions
were evaluated as markers of inﬂammation and destructive changes associated with arthritis.
Long-term preventive treatment with low-dose MTX signiﬁcantly inhibited the markers of both
inﬂammation and arthritis. EF or SSe when administered singly or in combination had no signiﬁcant
effect on given parameters in arthritic rats. EF but not SSe potentiated the beneﬁcial effects of MTX,
which resulted in a more signiﬁcant reduction of hind paw swelling, arthrogram scores and whole body
BMD decrease. EF had a tendency to improve also the effect of MTX on serum albumin and
nitrite/nitrate concentrations.
Our results indicate that EF may increase the preventive effect of MTX treatment in rat AA by
improving its anti-inﬂammatory and anti-arthritic effects.
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INTRODUCTION
Increasing interest in an inﬂuence of intestinal microﬂora
on human and animal health has resulted in attempts to
improve optimally its composition by using probiotics.
Probiotics are deﬁned as live cultures of microorganisms
that, if administered in sufﬁcient quantities, beneﬁcially
affectthehostbyimprovingitsintestinalmicrobialbalance
(Reid et al., 2003). They inﬂuence favourably both
development and stability of the microﬂora, inhibit
colonization by pathogens, inﬂuence the mucosal barrier
by their trophic effect on intestinal epithelium and
stimulate both speciﬁc and non-speciﬁc components of
the immune system (Isolauri et al., 2001; Tlaskalova ´-
Hogenova ´ et al., 2004). The bacteria most frequently used
asprobioticsarethosefromLactobacillusandBiﬁdobacter
strains. However, some non-pathogenic strains of E. coli
proved to be suitable for this purpose as well.
Enterococcus faecium (EF), like many other lactic-acid
bacteria in functional foods, can transiently colonize
the human intestine and exert beneﬁcial probiotic effect
(Belicova ´ et al., 1999). Signiﬁcant immunostimulatory
effects on both phagocytosis by neutrophils and antibody
production by EF have been described in several studies
(Mikes ˇ et al., 1995; Ferenc ˇı ´k et al., 2000). As a food
additive, this probiotic agent is available also in the
selenium-enriched form. Selenium is an essential trace
element with antioxidant properties able to modulate the
anti-inﬂammatory and immune responses (Rayman,
2000). Deﬁciencies in selenium attenuate especially the
cellular immune response by oxidative stress, and increase
the risk of bacterial and viral infections. Inﬂammatory and
arthritic manifestations of adjuvant arthritis (AA) in rats
signiﬁcantly worsened after 6 and 12 weeks of application
of selenium-deﬁcient diet (Parnham et al., 1983).
Selenium supplementation in RA patients did not decrease
the arthritic score but improved some symptoms of the
disease (Peretz et al., 2001). The combination of EF with
organic selenium may enhance the immunostimulatory
and anti-inﬂammatory actions of this probiotic agent.
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microﬂora could be associated with occurrence of diseases
that may have no relation to the bacteria living in
intestines; it may also increase susceptibility to infectious
diseases or worsen absorption of some drugs. Certain
association was observed among gastrointestinal system,
arthritis and immune system (Sartor, 1997; Cebra, 1999).
Patients with newly diagnosed RA have their intestinal
microﬂora composition altered (especially in the case of
Gram-positive anaerobic bacteria) in comparison with
healthy controls (Eerola et al., 1994). It has also been
suggested that in arthritis the intestinal defensive barrier is
disturbed (Malin et al., 1997). Short-term therapy with
Lactobacillus GG showed a tendency to increase the IgA
secretion and thus improve the mucosal barrier mecha-
nism (Hatakka et al., 2003). The positive alterations in
intestine ﬂora can be induced also by uncooked,
lactobacilli-rich, vegan diet. Decrease of RA activity
(Peltonen et al., 1997) or the subjective symptoms of the
disease (McDougall et al., 2002) were observed in RA
patients using the vegan diet.
Kano et al. (2002) have shown that oral intake of
Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1
prevents development of collagen-induced arthritis in
mice. On the other hand it has been suggested that the
Gram-positive bacteria belonging to the normal intestinal
ﬂora (e.g. Eubacterium aerofaciens, Lactobacillus casei)
may induce arthritis and the production of pro-
inﬂammatory cytokines in rats (Chen et al., 1999;
Simelyte et al., 2000). The beneﬁcial and the harmful
effects of probiotics are clearly strain-dependent, there-
fore it is important to test different probiotics and their
affect on the development and course of arthritis. This
work is continuation of our previous study with selenium-
enriched EF (Rovensky et al., 2002). The results of our
previous study proved that this probiotic agent had a
tendency to improve some inﬂammatory and arthritic
parameters in AA rats and signiﬁcantly potentiate the
preventive effect of methotrexate (MTX). MTX is widely
used in RA therapy for its antiinﬂammatory and
immunosuppressive effects. However, one of its side
effects is the damage of intestinal mucosa.
The purpose of the present study is to answer the
question whether the beneﬁcial effect of probiotic agent
selenium-enriched EF on the MTX treatment is a result of
the single EF, or selenium, or both of these components.
METHODS
Materials
MTX and sodium selenite pentahydrate (SSe) were
purchased as pure substances from Pliva-Lachema Ltd.
(Brno, Czech Republic). EF M74—the lyophilized
probiotic agent containing 360 £ 109=g CFU (colony
forming units) was prepared by MEDIPHARM (Husto-
pec ˇe, Czech Republic). Mycobacterium butyricum in
lyophilized form was purchased from Difco Laboratories
Co. Ltd. (Detroit, USA), and the incomplete Freund’s
adjuvant was purchased from Sigma-Aldrich Chemie
GmbH (Taufkirchen, Germany).
Animals
Male Lewis rats (170 ^ 10g; Charles River Wiga,
Sulzfeld, Germany) were maintained during the experi-
ment in standard animal facilities that comply with the
European Convention for the Protection of Vertebrae
Animals Used for Experimental and Other Scientiﬁc
Purposes. The animals were fed pelleted food
(TOP DOVO, Dobra ´ Voda, Slovak Republic) and had
free access to both food and water. The State Veterinary
and Food Committee of the Slovak Republic and the
Ethics Committee for Control of Animals Experimen-
tation on the National Institute of Rheumatic Diseases
approved the experimental protocol and all procedures.
Induction of Arthritis
The rats were injected with 0.1ml suspension of heat-
killed M. butyricum (12mg/ml) in incomplete Freund’s
adjuvant intradermally at the base of the tail.
Treatment
Tested substances were administered in corresponding
doses from day 0 (day of immunization) to day 50 of the
study. Lyophilized EF (15mg/kg), SSe (0.050mg/kg
containing 0.015mg/kg selenium), and their combinations
were prepared in distilled water to reach the required
concentration and were applied per os in once-daily dose,
5-timesaweek.MTXwaspreparedinsterilesalinetoyield
thedesiredconcentrationof0.3mg/kgin0.1mlsaline,and
appliedtwiceaweekperos(0.6mg/kgintotalperweek).A
freshsolutionofthetestedsubstanceswaspreparedoneach
day of the administration. The untreated groups received
vehicle(sterilesaline)inthesamemannerdailyfor50days.
Rat Groups
The animals were divided into the following 9 groups of
ten: Group 1: non-arthritic untreated controls; Group 2:
untreated rats with AA; Group 3: AA rats treated with EF;
Group 4: AA rats receiving SSe; Group 5: AA rats
administered the combination of EF þ SSe; Group 6: AA
rats treated with MTX; Group 7: AA rats treated with the
combination of MTX þ EF; Group 8: AA rats treated with
the combination of MTX þ SSe; Group 9: AA rats
administered the combination of MTX þ EF þ SSe.
Evaluated Parameters
Hind Paw Swelling
The volume of the hind paws swelling was measured with
an electronic water plethysmometer (UGO BASILE,
Comerio-Varese, Italy) on days 14, 21 and 28.
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The severity of arthritis was quantiﬁed by scoring each
pawfrom 1 to 5, based on increasing levels of swellingand
periarticular erythema. The sum of the scores for the limbs
was calculated as the arthritic index, with a maximum
possible score of 20 per rat. Arthrogram scores were
evaluated on days 14, 21 and 28.
Serum Albumin Levels
Serum albumin levels were measured on days 14, 21 and
28 in the rat serum by spectrophotometric method, using
SYS 1 kit (BM/Hitachi, Boehringer Mannheim, Germany)
on a Hitachi 911 automatic biochemical analyzer.
Serum Nitrite/nitrate
Nitrite/nitrate concentration in deproteinised serum was
determined by the method of Cortas and Waking (1990) on
days 14, 21 and 28. Cu-coated cadmium granules in
glycine buffer at pH 9.7 reduced nitrate and the resulting
nitrite was evaluated by Griess reaction.
Bone Mineral Density (BMD)
BMD was measured by dual-energy X-ray absorptiometry
(DEXA) using a Hologic QDR
w-4500 (Waldham, HA,
USA) with the equipment for measuring small laboratory
animals. The whole body BMD of rats was determined on
day 50 after immunization.
Bone Erosions
Bone changes, indicated by erosions of tarsal and
metatarsal bone structures of hind paws, were evaluated
from radiographic prints. They were taken on a computer
controlled X-ray generator (Philips Super 80CP, Hamburg,
Germany) on day 50 after immunization, using the
modiﬁed arthrogram scoring system (Welles et al., 1985).
Every hind paw radiograph was checked for matching to
oneofthe5degreesofboneerosion:degree1:osteoporosis
of the distal part of the tibia and the tarsal bones; degree 2:
hyperostosis with osteophytes in the tibiotarsal joint
region; degree 3: as in degree 2 plus hyperostosis with
osteophytesinthetarsometatarsaljointregion;degree4:as
in degree 3 plus hyperostosis with osteophytes in the tarso-
metatarsalophalangealjointregion;degree5:asindegree4
plus deformation of the joint spaces.
Statistical Analysis of the Results
One-way analysis of variance (ANOVA) was used for
statistical analysis of the results and p , 0:05 was taken as
the signiﬁcance limit for all comparisons.
RESULTS
Hind Paw Swelling
The hind paw swelling reﬂects both inﬂammatory and
arthritic changes occurring in rats with AA. Thevolume of
the swollen hind paws in arthritic rats on day 21 was about
twice of that found in healthy controls (Table I). The
statistically signiﬁcant decrease was observed in rats
treated with MTX compared to untreated arthritic
controls. The reduction of hind paw volume was more
pronounced in rats treated with the combination of
MTX þ EF than with MTX alone ðp , 0:05Þ: Selenium
alone had no effect on MTX treatment. The best
preventive effect observed with the 3-agent combination
of MTX þ EF þ SSe may be also the result of the
presence of EF in this treatment regiment. EF or SSe when
administered singly or in combination had no signiﬁcant
effect on hind paw swelling.
Arthrogram Scores
Arthrogram score is a more comprehensive variable that
indicates the severity of arthritis. Only MTX and its
combinations were associated with signiﬁcant decrease of
arthrogram scores (Table II). Similarly to hind paw
swelling, reductions in arthrogram scores were more
pronounced for the groups treated with combinations of
MTX with EF (MTX þ EF, MTX þ EF þ SSe).
TABLE I The effect of preventive treatment with methotrexate (MTX), E. faecium (EF), selenium (SSe) and their combinations on hind paws swelling
(ml) in AA rats
Groups of rats Day 14 Day 21 Day 28
Healthy controls 1.22 ^ 0.02 1.25 ^ 0.08 1.35 ^ 0.08
AA controls 2.20 ^ 0.23 2.31 ^ 0.17 2.18 ^ 0.22
AA treated with:
EF 2.11 ^ 0.44 2.20 ^ 0.37 2.09 ^ 0.28
SSe 2.09 ^ 0.26 2.20 ^ 0.24 2.12 ^ 0.27
EF þ SSe 2.15 ^ 0.19 2.36 ^ 0.21 2.19 ^ 0.25
MTX 1.79 ^ 0.27** 2.01 ^ 0.26* 1.85 ^ 0.23**
MTX þ EF 1.48 ^ 0.22***
† 1.69 ^ 0.33***
† 1.58 ^ 0.22***
†
MTX þ SSe 1.81 ^ 0.31** 1.98 ^ 0.38* 1.79 ^ 0.36*
MTX þ EF þ SSe 1.39 ^ 0.23***
† 1.65 ^ 0.41***
† 1.56 ^ 0.27***
†
Data represent mean values ^ SD for 10 rats. Signiﬁcantly different from arthritic control rats: *p , 0:05; **p , 0:01; ***p , 0:001: Signiﬁcantly different from arthritic
rats treated with MTX alone:
†p , 0:05:
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Serum albumin behaves as a negative acute phase reactant
in both rat as well as human arthritis. Lower levels of
serum albumin corresponded to higher levels of
inﬂammatory activity. The concentration of albumin in
the serum of arthritic controls was signiﬁcantly lower than
in healthy controls (HC vs AA p , 0:001). All treatments
containing MTX signiﬁcantly inhibited the serum albumin
decrease (Table III). EF potentiated the beneﬁcial effect of
MTX (on day 28). EF or SSe used singly and their
combination EF þ SSe without MTX did not inﬂuence
this inﬂammatory marker.
Serum Nitrite/nitrate Concentrations
Serum concentrations of nitrite/nitrate reﬂect nitric oxide
(NO) production in various tissues and inﬂammatory
responses. The clinical onset of AA was associated with
signiﬁcant rise in nitrite/nitrate concentrations. MTX
alone and its combinations with EF and SSe signiﬁcantly
decreased nitrite/nitrate concentrations during the whole
study compared to arthritic controls (Table IV). SSe, EF or
their combination EF þ SSe had no signiﬁcant effect on
the serum nitrite/nitrate concentrations, but EF potentiated
the beneﬁcial effect of MTX on day 28 of the study.
Whole Body BMD
Development of arthritis in both humans and rats is
associated with the development of osteopenia due to
the activation of pro-inﬂammatory cytokines. At the end
of the study (on day 50), AA rats had markedly lower
values of the whole body BMD in comparison with
healthy controls (Fig. 1). Evaluation of different
treatments showed that only the combinations
MTX þ EF and MTX þ EF þ SSe inhibited signiﬁcantly
the whole body BMD decrease in AA rats.
Evaluation of Bone Erosions
X-ray scans of AA rats on day 50 revealed destruction of
joint structures characteristic for arthritis. The radio-
graphic scores positively correlated with hind paw
swellings; bone erosions increased with increased
swelling. No changes were detected in healthy controls,
while arthritis was manifested by pronounced destructions
(Fig. 2). MTX and its combinations MTX þ EF, MTX þ
SSe signiﬁcantly reduced radiographic scores. The most
pronounced reduction was observed for 3-agent combi-
nation MTX þ EF þ SSe. EF or SSe administered singly
or in combination did not inﬂuence this parameter.
DISCUSSION
The purpose of our study was to evaluate the effect of the
probiotic agent EF and selenium on MTX treatment of AA
in rats. Since the effects on BMD and radiographic scores
were also investigated, the duration of the treatment
was longer (50 days) than usually administered for AA
TABLE II The effect of preventive treatment with methotrexate (MTX), E. faecium (EF), selenium (SSe) and their combinations on the arthrogram
score in rats with AA
Groups of rats Day 14 Day 21 Day 28
AA controls 16.67 ^ 1.87 19.13 ^ 1.83 19.33 ^ 1.87
AA treated with:
EF 14.63 ^ 5.15 17.13 ^ 2.95 18.25 ^ 3.20
SSe 15.00 ^ 2.78 18.38 ^ 2.20 19.38 ^ 2.72
EF þ SSe 16.25 ^ 1.91 17.38 ^ 1.50 19.75 ^ 2.43
MTX 10.50 ^ 2.62*** 14.88 ^ 3.31** 14.00 ^ 4.57**
MTX þ EF 7.50 ^ 1.20***
† 13.50 ^ 3.42*** 12.38 ^ 4.37***
MTX þ SSe 10.13 ^ 3.40*** 15.75 ^ 2.31** 14.88 ^ 4.73**
MTX þ EF þ SSe 7.30 ^ 2.06***
† 11.00 ^ 2.40***
† 11.25 ^ 3.08***
Data represent mean values ^ SD for 10 rats. Signiﬁcantly different from arthritic control rats: **p , 0:01; ***p , 0:001: Signiﬁcantly different from arthritic rats treated
with MTX alone:
†p , 0:05:
TABLE III The effect of preventive treatment with methotrexate (MTX), E. faecium (EF), selenium (SSe) and their combinations on serum albumin
concentrations (g/L) in rats with AA
Groups of rats Day 14 Day 21 Day 28
Healthy controls 33.18 ^ 1.02 34.55 ^ 1.86 34.95 ^ 1.84
AA controls 25.90 ^ 0.99 26.34 ^ 1.21 26.40 ^ 1.95
AA treated with:
EF 26.33 ^ 1.37 26.58 ^ 0.85 25.66 ^ 1.79
SSe 25.61 ^ 1.85 26.26 ^ 0.82 24.91 ^ 1.47
EF þ SSe 26.04 ^ 0.97 26.34 ^ 1.54 25.40 ^ 1.66
MTX 27.15 ^ 1.10* 29.06 ^ 2.78* 28.80 ^ 2.11*
MTX þ EF 27.81 ^ 2.10* 29.14 ^ 2.89* 29.21 ^ 1.24**
MTX þ SSe 27.34 ^ 1.56* 28.96 ^ 2.74* 28.84 ^ 1.48*
MTX þ EF þ SSe 28.02 ^ 2.62* 30.25 ^ 3.95* 29.87 ^ 2.00**
Data represent mean values ^ SD for 10 rats. Signiﬁcantly different from arthritic control rats: *p , 0:05; **p , 0:01:
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discontinuation of the therapy.
The results of our investigation conﬁrmed the
previously reported effect of MTX treatment in rats with
AA (Welles et al., 1985). MTX at a dose of
0.6mg/kg/week suppressed, but did not prevent, arthritis
development. In our study, MTX signiﬁcantly suppressed
the hind paw swelling and decreased the arthrogram
scores. EF but not SSe potentiated the beneﬁcial effect of
MTX, which resulted in a more signiﬁcant reduction of
hind paw swelling and arthrogram scores. Parnham et al.
(1987) have observed a weak inhibition of carrageenan
paw oedema and AA in rats with organo-selenium
compound, ebselen.
Serum albumin acts as a negative acute phase reactant
in rat arthritis, and the decrease of serum albumin levels
reﬂects the changes in synthesis of this protein in the liver
secondary to the activation of hepatic cells by inﬂamma-
tory cytokines, mainly IL-1 (Connolly et al., 1988). Our
results correlate with the observation that MTX markedly
prevents the albumin decrease in rat AA (Connolly et al.,
1988). The administration of EF was positively mani-
fested in both combinations MTX þ EF and MTX þ
EF þ SSe on day 28. The combination of MTX with SSe
had no additional effect compared to MTX alone. In
patients with RA, the concentration of selenium contai-
ning glutathione peroxidase in polymorphonuclear leuco-
cytes is decreased (Tarp, 1994). Supplementation with
selenium increases the concentration of selenium in serum
and erythrocytes but only weakly increases its concen-
tration in polymorphonuclear leucocytes, and that might
be the cause of its insufﬁcient anti-inﬂammatory effect in
arthritis.
NO, unstable free radical produced by the action of the
enzyme NO synthase (NOS) on L-arginine, is a mediator
of multiple physiologic functions, and may also mediate
local inﬂammation and tissue destruction (Stamler et al.,
1992). NO is involved in both initiation and development
of AA in rats (Oyanagui, 1994). Moreover, inhibitors of
NOS have been shown to suppress arthritis in several
animal models (Stefanovic-Racic et al., 1995; Cannon
et al., 1996) and increased NO levels have been found in
patients with RA (Ueki et al., 1996). Omata et al. (1997)
TABLE IV The effect of preventive treatment with methotrexate (MTX), E. faecium (EF), selenium (SSe) and their combinations on serum
nitrite/nitrate concentrations (nmol/ml) in rats with AA
Groups of rats Day 14 Day 21 Day 28
Healthy controls 39.75 ^ 4.83 38.76 ^ 8.57 40.94 ^ 4.71
AA controls 91.14 ^ 14.63 84.24 ^ 14.70 74.69 ^ 7.93
AA treated with:
EF 88.21 ^ 12.67 79.53 ^ 10.22 71.62 ^ 10.69
SSe 97.79 ^ 14.56 77.89 ^ 8.11 78.56 ^ 18.87
EF þ SSe 89.72 ^ 15.61 77.11 ^ 16.80 70.65 ^ 13.09
MTX 76.82 ^ 12.08* 71.34 ^ 8.40* 67.53 ^ 5.51*
MTX þ EF 75.51 ^ 8.14* 69.61 ^ 7.15* 58.85 ^ 10.97**
MTX þ SSe 75.81 ^ 11.54* 69.77 ^ 11.64* 64.51 ^ 9.95*
MTX þ EF þ SSe 74.17 ^ 11.74* 65.77 ^ 13.69* 57.97 ^ 13.16**
Data represent mean values ^ SD for 10 rats. Signiﬁcantly different from arthritic control rats: *p , 0:05; **p , 0:01:
FIGURE 1 The effect of E. faecium (EF), selenium (SSe), methotrexate
(MTX) and their combinations on whole body bone mineral density
(BMD) in rats assessed on day 50. Animals were grouped as follows:
(1) nonarthritic untreated controls; (2) AA untreated controls; (3) AA rats
treated with EF 15mg/kg, 5 days a week; (4) AA rats treated with SSe
(0.050mg/kg containing 0.015mg/kg selenium), 5 days a week; (5) AA
rats treated with combination EF þ SSe; (6) AA rats treated with MTX
0.6mg/kg/week; (7) AA rats treated with combination MTX þ EF;
(8) AA rats treated with combination MTX þ SSe; (9) AA rats treated
with combination MTX þ EF þ SSe. Data represent mean values ^ SD
for 10 rats. Signiﬁcantly different from arthritic control rats: *p , 0:05:
FIGURE 2 The effect of E. faecium (EF) selenium (SSe), methotrexate
(MTX) and their combinations on radiographic scores in rats assessed on
day 50. Designation of rat groups as in Fig. 1. Data represent mean
values ^ SD for 10 rats. Signiﬁcantly different from arthritic control rats:
*p , 0:05; **p , 0:01:
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macrophages of rats with AA. In our study, markedly
increased serum nitrite/nitrate concentrations were
measured in AA rats. EF or SSe administered singly or
in combination did not decrease the concentration of
nitrite/nitrate but EF potentiated the inhibitory effect of
MTX on day 28.
AA rats developed marked osteopenia predominantly in
the distal periarticular region of the femur as a result of the
suppression of bone formation and increased bone
resorption (Bonnet et al., 1993). Suzuki et al. (1997)
reported short-term low doses of MTX to ameliorate
abnormal bone metabolism and decrease the bone loss in
AA. In AA rats, MTX in the dose of 3mg/kg/week
suppressed arthritis and restored the decreased osteogenic
activity of bone marrow cells, and signiﬁcantly increased
periarticular BMD in the femur. The lower dose of
0.3mg/kg/week had no effect on femoral BMD. In our
study, MTX (0.6mg/kg/week) had no effect on the whole
body BMD in rats. Interestingly EF alone, similarly to
MTX, was ineffective. But EF in combination with MTX
signiﬁcantly reduced the whole body BMD loss in AA
rats. This observation needs further study and measure-
ments of BMD in different sites (e.g. BMD of femur or
tibia).
Bone erosions of hind paws are typical sign of chronic
arthritis; reduction of radiographic response in AA with
MTX is dose-dependent. Low doses of MTX (0.1 or
0.2mg) did not normalize the radiographic ﬁndings in AA
(Kawai et al., 1997). Morgan et al. (2001) found that MTX
at 1mg/kg/week resulted in mean total radiographic
scores not different from healthy controls; lower or higher
doses of MTX were less effective. In our experiment,
MTX 0.6mg/kg/week signiﬁcantly decreased the radio-
graphic scores. The more pronounced reduction of
radiographic scores with 3-agent combination MTX þ
EF þ SSe may be result of additional effect of probiotic
agent, SSe or their combination.
Our results demonstrate that administration of probiotic
agent EF alone does not worsen the clinical, inﬂammatory,
or destructive markers of AA. On the contrary, it
potentiates the beneﬁcial effect of MTX treatment on
arthritis-associated inﬂammation and destruction. Our
results also show that the beneﬁcial effect of selenium-
enriched EF observed in our previous study (Rovensky
et al., 2002) results mainly from the bacteria and not from
selenium. The possible explanation may be the altered
intestinal absorption of MTX after colonization of gut by
this probiotic agent. During the experiment no diarrhea
was observed in rats. Mao et al. (1996) have shown that
administration of lactobacilli, especially L. plantarum,i s
helpful in reducing the severity of the MTX-induced
enterocolitis in rats. Due to the fact that EF not only
increases the efﬁcacy of MTX treatment but may
favourably inﬂuence the intestinal ﬂora and may protect
against related infectious diseases, we can see rationale for
the use of this probiotic agent for the MTX treatment of
arthritis.
The focus of the present study is on the long-term
preventive treatment of arthritic rats; further studies are
needed to explore the role of EF in MTX therapy regimen
and the possible therapeutical use of this probiotic agent in
arthritis.
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